Report cover image

Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Aug 26, 2024
Length 483 Pages
SKU # GBDT19176708

Description

Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Contrast Agents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Contrast agents are substances applied in medical imaging to increase visibility of internal structures like organs, blood vessels, and other tissues. Before the imaging operation, they are frequently injected into the body or taken orally to boost contrast and enhance the visibility of specific structures.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Contrast Agents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Contrast Agents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Contrast Agents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

483 Pages
    • Contrast Agents Overview
    • Contrast Agents - Pipeline Products by Stage of Development
    • Contrast Agents - Pipeline Products by Segment
    • Contrast Agents - Pipeline Products by Territory
    • Contrast Agents - Pipeline Products by Regulatory Path
    • Contrast Agents - Pipeline Products by Estimated Approval Date
    • Contrast Agents - Ongoing Clinical Trials
    • Contrast Agents Companies - Pipeline Products by Stage of Development
    • Contrast Agents - Pipeline Products by Stage of Development
    • 3B Pharmaceuticals GmbH Company Overview
    • 5M Biomed LLC Company Overview
    • Abscint nv Company Overview
    • AC Immune SA Company Overview
    • AccuNovo Biotechnologies Inc Company Overview
    • AdAlta Ltd Company Overview
    • Adamas Nanotechnologies Inc Company Overview
    • Adiposs SA Company Overview
    • Aestas Pharma Inc Company Overview
    • Affibody AB Company Overview
    • Akrotome Imaging Inc Company Overview
    • Alume Biosciences Inc Company Overview
    • Alzeca Biosciences Inc Company Overview
    • Amydis Inc Company Overview
    • Antaros Medical AB Company Overview
    • APRINOIA Therapeutics Inc Company Overview
    • Ascelia Pharma AB Company Overview
    • Astellas Pharma Inc Company Overview
    • Augurix SA Company Overview
    • Auxano Biomedical, LLC. (Inactive) Company Overview
    • Avelas Biosciences Inc Company Overview
    • B-Aegis Life Sciences & Research Pvt Ltd Company Overview
    • Bayer AG Company Overview
    • BBS NanoTechnology Ltd Company Overview
    • Beckman Research Institute Of The City Of Hope Company Overview
    • Blaze Bioscience Inc Company Overview
    • Bracco Imaging SpA Company Overview
    • Brown University Company Overview
    • Case Western Reserve University Company Overview
    • Cavatar LLC Company Overview
    • Cell2in Company Overview
    • Cellectar Biosciences Inc Company Overview
    • Centre National de la Recherche Scientifique Company Overview
    • Centurion BioPharma Corp Company Overview
    • Chinese Academy of Sciences Company Overview
    • Clarity Pharmaceuticals Ltd Company Overview
    • ClearNano Inc Company Overview
    • Collagen Medical LLC Company Overview
    • Cosmo Pharmaceuticals NV Company Overview
    • Curadel LLC Company Overview
    • CytoSite BioPharma Inc Company Overview
    • Daewoong Pharmaceutical Co Ltd Company Overview
    • Daimroc Imaging Company Overview
    • Diaprost AB Company Overview
    • DongKook Lifescience Co Ltd Company Overview
    • Drexel University Company Overview
    • Duke University Company Overview
    • Edinburgh Molecular Imaging Ltd Company Overview
    • Emory University Company Overview
    • Enigma Biomedical Group Inc Company Overview
    • EOS Biosciences Inc (Inactive) Company Overview
    • Expesicor Inc Company Overview
    • Ferric Contrast Inc Company Overview
    • GE HealthCare Technologies Inc Company Overview
    • Georgia State University Company Overview
    • H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview
    • Hana Pharm Co Ltd Company Overview
    • Harvard University Company Overview
    • Hebrew University of Jerusalem Company Overview
    • Helmholtz Center Dresden Rossendorf Company Overview
    • Helmholtz Center Munich German Research Center for Health and Environment GmbH Company Overview
    • Hong Kong Baptist University Company Overview
    • Hong Kong Polytechnic University Company Overview
    • Houston Methodist Research Institute Company Overview
    • Hugo W. Moser Research Institute at Kennedy Krieger Inc Company Overview
    • IC Targets AS Company Overview
    • ImaginAb Inc Company Overview
    • Imagion Biosystems Inc Company Overview
    • iMax Diagnostic Imaging Ltd Company Overview
    • IMRCP Laboratory Company Overview
    • Indi Molecular Inc Company Overview
    • Indian Council of Medical Research Company Overview
    • Indian Institute of Technology Delhi Company Overview
    • Inherent Targeting Inc Company Overview
    • Inlighta Biosciences LLC Company Overview
    • InnoMedica Holding AG Company Overview
    • Innopharmax Inc Company Overview
    • Intuitive Surgical Inc Company Overview
    • Inventera Pharmaceutical Co Ltd Company Overview
    • Iowa State University Company Overview
    • Johns Hopkins University Company Overview
    • J-Pharma Co Ltd Company Overview
    • King's College London Company Overview
    • Knowledgepie Pvt Ltd Company Overview
    • Korea University Guro Hospital Company Overview
    • LadeRx LLC Company Overview
    • Lantheus Holdings Inc Company Overview
    • Lantheus Medical Imaging Inc Company Overview
    • Ligand Pharmaceuticals Inc Company Overview
    • Lightpoint Medical Ltd Company Overview
    • Lipella Pharmaceuticals Inc Company Overview
    • Louisiana State University Company Overview
    • Lument AB Company Overview
    • Macquarie University Company Overview
    • Mallinckrodt Institute of Radiology Company Overview
    • Manzanita Pharmaceuticals Inc Company Overview
    • Massachusetts General Hospital Company Overview
    • Massachusetts Institute of Technology Company Overview
    • Mayo Clinic Company Overview
    • MediBeacon Inc Company Overview
    • Memorial Sloan Kettering Cancer Center Company Overview
    • Microbial Medical Inc Company Overview
    • Microvascular Therapeutics LLC Company Overview
    • Molecular Theranostics LLC Company Overview
    • Monash University Company Overview
    • Nanosion Co Ltd Company Overview
    • Nanovista Inc Company Overview
    • National University of Singapore Company Overview
    • Neuramedy Co Ltd Company Overview
    • NeuroScientific Biopharmaceuticals Ltd Company Overview
    • Neurovation Labs Inc Company Overview
    • Nextrast Inc Company Overview
    • Nirvana Sciences Inc Company Overview
    • Northwestern University Company Overview
    • Novara Therapeutics Ltd Company Overview
    • NuvOx Pharma LLC Company Overview
    • On Target Laboratories LLC Company Overview
    • OncoNano Medicine Inc Company Overview
    • Ospedaliero Ospedali Galliera Company Overview
    • pHLIP Inc Company Overview
    • Photocure ASA Company Overview
    • Photolitec LLC Company Overview
    • Polarean Imaging PLC Company Overview
    • Polyaurum LLC Company Overview
    • Praxis Pharmaceutical SAU Company Overview
    • Precision Molecular Inc Company Overview
    • Princeton University Company Overview
    • Quest Medical Imaging BV Company Overview
    • QurCan Therapeutics Inc Company Overview
    • Radiopharm Theranostics Ltd Company Overview
    • Respiratorius AB Company Overview
    • Reveal Pharmaceutical Inc Company Overview
    • Rice University Company Overview
    • Roche Diagnostics Company Overview
    • Royal College of Surgeons Ireland Company Overview
    • SANOCHEMIA Pharmazeutika GmbH Company Overview
    • SBI Pharmaceuticals Co Ltd Company Overview
    • Serac Ltd Company Overview
    • SG Endocrine Research LLC Company Overview
    • Signablok Inc Company Overview
    • Sirtex Medical Ltd Company Overview
    • Society of Nuclear Medicine and Molecular Imaging Company Overview
    • Solstice Pharmaceuticals BV Company Overview
    • Sonnest Inc Company Overview
    • Sorbonne Paris Cite Company Overview
    • Southern Illinois University Carbondale Company Overview
    • SPAGO Nanomedical AB Company Overview
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • Stanford University Company Overview
    • Stanford University School of Medicine Company Overview
    • SunTech Medical Inc Company Overview
    • SurgiMab SAS Company Overview
    • SurgVision GmbH Company Overview
    • Telix Pharmaceuticals Ltd Company Overview
    • The Chinese University of Hong Kong Company Overview
    • Theragnostic Technologies Inc Company Overview
    • Theragnostics Ltd Company Overview
    • Thomas Jefferson University Company Overview
    • TomoWave Laboratories Inc Company Overview
    • Trace Biosciences Inc Company Overview
    • University College London Company Overview
    • University Health Network Company Overview
    • University of Arizona Company Overview
    • University of Bordeaux Company Overview
    • University of California Davis Company Overview
    • University of California San Diego Company Overview
    • University of California San Francisco Company Overview
    • University of Central Florida Company Overview
    • University of Chicago Company Overview
    • University of Edinburgh Company Overview
    • University of Gottingen Company Overview
    • University of Illinois at Urbana-Champaign Company Overview
    • University of Louisville Company Overview
    • University of Michigan Company Overview
    • University of Minnesota Company Overview
    • University of Missouri Company Overview
    • University of North Carolina Company Overview
    • University of Oklahoma Company Overview
    • University of Oxford Company Overview
    • University of Pennsylvania Company Overview
    • University of Pittsburgh Company Overview
    • University of Tennessee Company Overview
    • University of Texas MD Anderson Cancer Center Company Overview
    • University of Texas Southwestern Medical Center Company Overview
    • University of Toronto Company Overview
    • University of Toulouse Company Overview
    • University of Tsukuba Company Overview
    • University of Virginia Company Overview
    • University of Washington Company Overview
    • University of Wisconsin Madison Company Overview
    • VA Ann Arbor Healthcare System Company Overview
    • Vanderbilt University Company Overview
    • Vascular BioSciences Company Overview
    • Vect-Horus SAS Company Overview
    • Vergent Bioscience Inc Company Overview
    • Verity Pharmaceuticals Inc Company Overview
    • Videns og Forskningscenter for Alternativ Behandling Company Overview
    • Voyageur Pharmaceuticals Ltd Company Overview
    • Vyripharm Biopharmaceuticals Company Overview
    • Washington University in St Louis Company Overview
    • Wayne State University Company Overview
    • Weizmann Institute of Science Company Overview
    • Xemed LLC Company Overview
    • XN Biotechnologies LLC Company Overview
    • Yale University Company Overview
    • Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd Company Overview
    • Aug 15, 2024: New Method Could Lower Radiotherapy Doses For Some Cancer Patients
    • Aug 15, 2024: Study Confirms Frequency of Undetected Responsiveness in Severe Brain Injury
    • Aug 08, 2024: Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024
    • Aug 08, 2024: Advanced MRI Scans Help Identify One in Three Concussion Patients with `Hidden Disease'
    • Aug 07, 2024: Consun Pharmaceutical : Drug Registration Approval for Iopromide Injection
    • Aug 01, 2024: Polarean Imaging Announces FDA submission to expand minimum age for XENOVIEW
    • Jul 31, 2024: New Xenon MRI System trade-in agreement entered with the University of Kansas Medical Center
    • Jul 25, 2024: Novel PET Imaging Tool Identifies Early Signs of Inflammatory Bowel Disease and Predicts Response to Treatment
    • Jul 25, 2024: Immunis Joins Hands With Springbok Analytics on MRI-based AI Muscle Analysis Technology
    • Jul 24, 2024: Sharing Brain Images Can Foster New Neuroscience Discoveries
    • Jul 23, 2024: FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent
    • Jul 15, 2024: Vanderbilt Scientists Develop New Tool That Could Lead to Noninvasive "liquid biopsies"
    • Jul 11, 2024: Hyperfine to Announce Second Quarter 2024 Financial Results on August 8, 2024
    • Jul 09, 2024: AI-Powered Antenna Revolutionizes Bone Fracture Diagnosis
    • Jul 08, 2024: Domestic Launch of the In Vitro Diagnostic Pharmaceutical "Shionogi MIC Dry Plate Cefiderocol"
    • Jun 21, 2024: NX Development Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan
    • Jun 18, 2024: Cosmo's oral diagnostic drug Lumeblue receives approval of New Drug Application in China
    • Jun 18, 2024: China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-Release Tablets Approved for Marketing in China
    • Jun 17, 2024: Ezra Launches Partnership with AMRIC Health to Enable Whole-Body MRI Screenings in New York Clinics
    • Jun 12, 2024: Sino Biopharmaceutical : Voluntary Announcement Approval for Marketing of Gadoteridol Injection
    • Jun 12, 2024: SNMMI 2024 Annual Meeting Spotlights Cutting-Edge Research, Spurring Innovation Across the Field
    • Jun 03, 2024: Hyperfine to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024
    • May 27, 2024: Telix seeks prostate cancer imaging kit approval from FDA
    • May 23, 2024: IXICO Announces Alzheimer's Disease (AD) Trial Contract Win
    • May 22, 2024: HKU Engineering Team Enhances Stereotactic Neurosurgery Precision Using MRIGuided Multi-Stage Robotic Positioner
    • May 14, 2024: Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update
    • May 08, 2024: Polarean's Xenon MRI to be Featured at Upcoming ATS 2024 Conference
    • May 07, 2024: Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024
    • May 07, 2024: University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
    • May 06, 2024: JNM Supplement Highlights Nuclear Medicine Innovation in China
    • May 02, 2024: Ascelia Pharma Successfully Meets Primary Endpoint With Strong Headline Results in Orviglance Phase 3 Study
    • Apr 30, 2024: Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy
    • Apr 28, 2024: CYTALUX Real-World Experience Presented at the American Association for Thoracic Surgery 104th Annual Meeting
    • Apr 17, 2024: Korean, US Researchers Develop New Dual Fluorescence Imaging Technique for Precision Lung Cancer Surgery
    • Apr 16, 2024: Clinical Trial Looks to Improve Treatment of Early-Stage Breast Cancer
    • Apr 12, 2024: Hengrui Pharmaceutical's Three Innovative Drugs HRS-9231 Injection, SHR-4597 Inhalation and SHR-2173 Injection Were Approved for Clinical Trials
    • Apr 08, 2024: European Association of Urology (EAU) 2024 Congress Features New Data on Modern Technology Use in Bladder Cancer Care
    • Apr 01, 2024: UC San Diego Receives $6.7M to Develop Whole-Body Inflammation Imaging
    • Mar 28, 2024: New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
    • Mar 25, 2024: Sino Biopharmaceutical: Voluntary Announcement Approval for Marketing of Iopromide Injection
    • Mar 20, 2024: MD Anderson Research Highlights for March 20, 2024
    • Mar 19, 2024: MINDSET Integrated And US Radiology Specialists Announce Strategic Agreement On Brain Injury Assessment
    • Mar 14, 2024: Subtle Medical Supports R01 Grant for AI-Powered Pediatric Imaging Secured with Researchers at Boston Children's Hospital and Massachusetts General Hospital
    • Mar 05, 2024: NX Development is Granted Orphan-Drug Designation Status by US FDA for Gleolan in Ovarian and Related Cancers
    • Feb 29, 2024: Medtronic Files ITC Action Against Axonics to Stop Unauthorized Use of Medtronic Innovations
    • Feb 28, 2024: Collaborative Development of AI Technology to Precisely Extract Areas Suspected of Glioma from MRI Images
    • Feb 08, 2024: New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
    • Feb 07, 2024: Isotopia USA is thrilled to announce its new partnership with E Solutions and Comfort Systems USA to build out its North American headquarters and US GMP manufacturing center
    • Jan 29, 2024: Photocure Partner Asieris Presented Clinical Trial and Real-World Data on Hexvix in China at ASCO GU 2024
    • Jan 29, 2024: Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU
    • Jan 28, 2024: Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery
    • Jan 19, 2024: Innovative Imaging solution offers potential breakthrough in endometriosis detection
    • Jan 12, 2024: Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results
    • Jan 03, 2024: Case Western Reserve Researchers Land $1.1m National Science Foundation Grant to Advance Safer, Faster and Less Expensive Medical-Imaging Technology
    • Dec 19, 2023: Study Discovers Novel Biomarker for Vascular Aging and Neurodegeneration
    • Dec 18, 2023: Heart Vest Could Help Predict Sudden Cardiac Death Risk
    • Dec 15, 2023: Spago Nanomedical Reports Positive Top Line Data from Clinical Phase IIa Study SPAGOPIX-02 In Patients with Endometriosis
    • Dec 15, 2023: Photocure Partner Asieris To Present Unpublished Clinical Trial and Real-World Data on Hexvix in China at ASCO GU 2024
    • Dec 13, 2023: Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense HER2 Imaging Agent
    • Dec 13, 2023: Vergent Bioscience Initiates Phase 2, Multi-Center VISUALIZE Study Evaluating Efficacy of Tumor-targeted Fluorescent Imaging Agent VGT-309 in Lung Cancer Surgeries
    • Dec 12, 2023: Bracco wins EU approval for MRI contrast agent
    • Dec 11, 2023: Guerbet announces marketing authorisation approval of Elucirem (Gadopiclenol) in the European Union
    • Dec 01, 2023: SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy
    • Nov 27, 2023: Guerbet to Spotlight Diagnostic Solutions at the 2023 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting
    • Nov 22, 2023: Bayer Championing Advancements in Radiology Pipeline and Accelerating AI Innovation
    • Nov 22, 2023: Novel MRI Reveals Brain Changes in Long-COVID Patients
    • Nov 20, 2023: Biggest Prostate Cancer Screening Trial in Decades to Start in UK
    • Nov 14, 2023: Amydis Receives $3.4 million NIH Commercialization Readiness Pilot Grant Award to Map Heterogeneity of Alzheimer's Diseases in Human Clinical Trial Using Novel Retinal Tracer
    • Nov 06, 2023: CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
    • Nov 02, 2023: Guerbet to Spotlight Diagnostic and Interventional Solutions at the 2023 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting
    • Nov 02, 2023: Amydis Launches Phase 2 Glaucoma Clinical Program Using Novel Retinal Tracer to Detect Amyloid Beta
    • Oct 25, 2023: Ligand To Report Third Quarter 2023 Financial Results On November 8
    • Oct 19, 2023: Hyperfine to Announce Third Quarter Financial Results on November 9, 2023
    • Oct 16, 2023: Researchers Develop Innovative Technique for Distinguishing Tumor from Normal Tissue
    • Oct 12, 2023: Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress
    • Oct 12, 2023: Vueway (Gadopiclenol) Receives Positive CHMP Opinion
    • Oct 09, 2023: Imagion Presents Ovarian Cancer Data at AACR Conference
    • Oct 09, 2023: France Concludes There Is Insignificant Cost Difference Between White Light and Blue Light Cystoscopy Use When Applying Ccafu Guidelines
    • Oct 07, 2023: Photocure Partner Asieris to Present First Results for Its Hexvix Phase III Clinical Trial in China at the SIU 2023 Annual Meeting
    • Oct 04, 2023: Northwestern's First Woman Director of Bands to Retire
    • Oct 02, 2023: Human Disease Simulator Lets Scientists Choose Their Own Adventure
    • Sep 21, 2023: Bracco Imaging Announces Global Agreement With Subtle Medical
    • Sep 15, 2023: New Test Helps Drug Discoverers Identify Future Cancer Treatments
    • Sep 14, 2023: Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media
    • Sep 13, 2023: Multi-Institutional Center for the Mechanical Control of Chemistry Awarded $20M CCI Grant
    • Sep 11, 2023: Phase 2 Data Demonstrate Potential of Vergent Biosciences' Tumor-Targeted Fluorescent Imaging Agent to Improve Success of Lung Cancer Surgeries
    • Sep 08, 2023: Polarean Imaging : Partnership with VIDA To Streamline Adoption of Advanced MRI of the Lungs
    • Sep 08, 2023: Polarean Partners with VIDA to Streamline Adoption of Advanced MRI of the Lungs
    • Sep 07, 2023: Simple Contrast Ultrasound Scan Resolves Indeterminate MR and CT
    • Sep 06, 2023: Vanderbilt Researchers Develop Innovative Plasmonic Nanotweezer to More Rapidly Trap Potentially Cancerous Nanosized Particles
    • Sep 06, 2023: Isotopia Issues a Call to Action to the Radionuclide Therapy Industry
    • Aug 30, 2023: Andrew Papachristos Named New Director of Institute for Policy Research
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.